Scribd Logo
Upload

Welcome to Scribd!

  • Aurobindo Pharma Receives USFDA Approval For Telmisartan Tablets (Company Update)

    Uploaded by

    Shyam Sunder
    39 views1 page
    Aurobindo Pharma received FDA approval to manufacture and market Telmisartan tablets in the US. Telmisartan is used to treat essential hypertension and has an estimated US market size of $92 million. This is Aurobindo Pharma's 46th ANDA approval from their Hyderabad, India facility for manufacturing oral non-antibiotic products, bringing their total ANDA approvals to 211.

    Original Description:

    Original Title

    Aurobindo Pharma receives USFDA Approval for Telmisartan Tablets [Company Update]

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Aurobindo Pharma received FDA approval to manufacture and market Telmisartan tablets in the US. Telmisartan is used to treat essential hypertension and has an estimated US market size of $92 million. This is Aurobindo Pharma's 46th ANDA approval from their Hyderabad, India facility for manufacturing oral non-antibiotic products, bringing their total ANDA approvals to 211.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    39 views1 page

    Aurobindo Pharma Receives USFDA Approval For Telmisartan Tablets (Company Update)

    Uploaded by

    Shyam Sunder
    Aurobindo Pharma received FDA approval to manufacture and market Telmisartan tablets in the US. Telmisartan is used to treat essential hypertension and has an estimated US market size of $92 million. This is Aurobindo Pharma's 46th ANDA approval from their Hyderabad, India facility for manufacturing oral non-antibiotic products, bringing their total ANDA approvals to 211.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 1

    

    WK6HSWHPEHU

    $XURELQGR3KDUPDUHFHLYHV86)'$$SSURYDOIRU7HOPLVDUWDQ7DEOHWV
    
    $XURELQGR 3KDUPD /LPLWHG LV SOHDVHG WR DQQRXQFH WKDW WKH FRPSDQ\ KDV UHFHLYHG WKH ILQDO
    DSSURYDO IURP WKH 86 )RRG  'UXJ $GPLQLVWUDWLRQ 86)'$  WR PDQXIDFWXUH DQG PDUNHW
    7HOPLVDUWDQ7DEOHWV863PJPJDQGPJ $1'$ 
    
    7KH DSSURYHG $1'$ LV ELRHTXLYDOHQW DQG WKHUDSHXWLFDOO\ HTXLYDOHQW WR WKH UHIHUHQFH OLVWHG GUXJ
    SURGXFW 5/' 0LFDUGLV7DEOHWVRI%RHKULQJHU,QJHOKHLP3KDUPDFHXWLFDOV,QF
    
    7HOPLVDUWDQ7DEOHWVDUHLQGLFDWHGLQWKHWUHDWPHQWRIHVVHQWLDOK\SHUWHQVLRQDQGKDVDQHVWLPDWHG
    PDUNHWVL]HRI860LOOLRQIRUWKHWZHOYHPRQWKVHQGLQJ-XO\DFFRUGLQJWR,06
    
    7KLV LV WKH WK $1'$ WR EH DSSURYHG RXW RI 8QLW 9,, IRUPXODWLRQ IDFLOLW\ LQ +\GHUDEDG ,QGLD IRU
    PDQXIDFWXULQJ 2UDO 1RQ$QWLELRWLF SURGXFWV $XURELQGR QRZ KDV D WRWDO RI  $1'$ DSSURYDOV
     )LQDO DSSURYDOV LQFOXGLQJ  IURP $XUROLIH 3KDUPD //& DQG  7HQWDWLYH DSSURYDOV  IURP
    86)'$
    
    $ERXW$XURELQGR3KDUPD/LPLWHG
    $XURELQGR 3KDUPD /LPLWHG ZZZDXURELQGRFRP  KHDGTXDUWHUHG DW +\GHUDEDG ,QGLD PDQXIDFWXUHV JHQHULF
    SKDUPDFHXWLFDOV DQG DFWLYH SKDUPDFHXWLFDO LQJUHGLHQWV 7KH FRPSDQ\V PDQXIDFWXULQJ IDFLOLWLHV DUH DSSURYHG E\
    VHYHUDOOHDGLQJUHJXODWRU\DJHQFLHVOLNH86)'$8.0+5$-DSDQ30'$:+2+HDOWK&DQDGD0&&6RXWK$IULFD
    $19,6$ %UD]LO 7KH FRPSDQ\V UREXVW SURGXFW SRUWIROLR LV VSUHDG RYHU  PDMRU WKHUDSHXWLFSURGXFW DUHDV
    HQFRPSDVVLQJ $QWLELRWLFV $QWL5HWURYLUDOV &96 &16 *DVWURHQWHURORJLFDOV DQG $QWL$OOHUJLFV VXSSRUWHG E\ DQ
    RXWVWDQGLQJ5 'VHWXS7KH&RPSDQ\LVPDUNHWLQJWKHVHSURGXFWVJOREDOO\LQRYHUFRXQWULHV
    

    
    )RUIXUWKHULQIRUPDWLRQSOHDVHFRQWDFW
    ,QYHVWRU5HODWLRQV
    $XURELQGR3KDUPD/LPLWHG
    
    &RUSRUDWH2II:DWHU0DUN%XLOGLQJ/HYHO
    3ORW1R6XUYH\1R
    .RQGDSXU+LWHFK&LW\+\GHUDEDG
    
    5HJ2II3ORW1R0DLWULYLKDU
    $PHHUSHW+\GHUDEDG
    

    3KRQH
    (PDLOLU#DXURELQGRFRP
    :HEVLWHZZZDXURELQGRFRP

    You might also like